Korea's Ministry of Food and Drug Safety flagged 26 advertisers after an intensive review of online weight-loss food advertising timed to summer demand.
The shared pattern
The flagged approaches cluster into a few types.
1. Names that evoke pharmaceuticals
Ordinary foods such as olive oil were given names evoking prescription drugs, priming consumers to expect medicine-grade effects from the product name alone.
2. Exaggerated efficacy claims
Copy used terms such as detox, body-fat elimination and appetite suppression — claims ordinary foods cannot make.
3. Trust signals plus repetition
Promotion fronted by celebrities and AI-generated virtual personas was combined with repeated short-form exposure to drive sales: familiarity converted into trust through frequency.
Scale and pricing
Roughly 600,000 units were involved, worth KRW 11.5 billion. Some products were found selling at 1.8x to 27.5x their purchase cost.
The ministry urged consumer caution toward advertising that claims medicine-level efficacy.
The marketer's takeaway
This is a compliance case file, but it is also evidence of what currently works in the market. AI virtual personas and repeated short-form exposure demonstrably produced sales.
The question is what you place them on top of. The same tactics stacked on verifiable claims compound into an asset; stacked on exaggeration, they become grounds for enforcement.
If you want a review of your claim language before it ships, get in touch.